{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"}],"units":"Participants"}],"description":"Number of patients who respond with agree/strongly agree to \"I found survey acceptable to clarify my preferences\"","groups":[{"description":"Participants diagnosed participating in the questionnaire portion of the study.","id":"OG000","title":"Pilot Testing: Participants With Newly-diagnosed Hematologic Malignancies"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Participants with newly-diagnosed hematologic malignancies who completed Best-Worst Scaling (BWS) survey.","reportingStatus":"POSTED","timeFrame":"Up to 7 days after treatment decision","title":"Acceptability of Best-Worst Scaling (BWS) Survey to Patients","type":"SECONDARY","unitOfMeasure":"Participants"}